By creator to www.oaoa.com
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Feb 22, 2021–
Paragonix Technologies, the main hypothermic cardiothoracic organ preservation supplier, introduced right this moment the first-in-man scientific use of the one FDA cleared chilly storage machine for donor lungs, its LUNGguard™ Donor Lung Preservation System, by Duke University Hospital.
This press launch options multimedia. View the total launch right here: https://www.businesswire.com/news/home/20210222005619/en/
Paragonix Broadcasts First-in-Man use of LUNGguard™ Donor Lung Preservation System by Duke Hospital (Picture: Enterprise Wire)
“Donor lungs are delicate to harm and the present ice storage of lungs dangers mobile harm, particularly with the rising transport distances and occasions now skilled by lung transplant facilities,” stated John Haney, MD, MPH, Surgical Director, Duke Lung Transplant. Dr Haney was the implanting transplant surgeon on the primary 4 circumstances utilizing the LUNGguard system. “Duke Well being is dedicated to pioneering new improvements that profit transplant sufferers and altering the best way donor lungs are transported has this potential.”
The primary-in-the-world use of the LUNGguard system preserved donor lungs for 7 hours on their journey to supply a affected person affected by Idiopathic Pulmonary Fibrosis (IPF) with new lungs. For the reason that preliminary first-in-man, the Duke workforce has carried out an extra 4 lung transplantations utilizing the LUNGguard System. These early circumstances have demonstrated the flexibility of the machine in a number of functions together with DCD and DBD donors, complete ischemic occasions from three hours to 12 hours, and indications various from emphysema to cystic fibrosis.
The LUNGguard System represents a radical advance from ice and off-the-shelf coolers that has been the standard-of-care for over 50 years of organ transplantation. For the primary time, transplant groups have entry to an FDA cleared and CE marked hypothermic lung preservation machine that may exactly keep and monitor the setting mandatory for donor lungs.
“At Carolina Donor Providers, our mission is to maximise the passing of the heroic present of life from one individual to a different via organ donation. We’re continually embracing new applied sciences that may assist safeguard organs and guarantee higher outcomes for these sufferers ready for the present of life,” stated Danielle Niedfeldt, President and CEO of Carolina Donor Providers, the organ donation group that supported these circumstances. “I’m honored that our workforce might be a part of the first-in-man use of the LUNGguard system and we’re excited by its optimistic influence in lung transplantation and saving extra lives.”
The event of this method has been supported by a collaboration between Paragonix and the Lung Transplant Foundation, a number one lung transplant affected person advocacy group. “The LUNGguard machine is a undertaking that we now have been engaged on with Paragonix for the previous three years, as a result of we noticed the essential want for this expertise in lung transplantation. To have the ability to assist one other IPF affected person within the first-in-man case couldn’t have been extra vital to me personally,” stated Jeffery Goldstein, President and Founding father of the Lung Transplant Basis and lung transplant recipient.
The LUNGguard System is the newest addition to the Paragonix portfolio of organ preservation and transport methods. It’s constructed on the identical confirmed expertise structure because the Paragonix™ SherpaPak Cardiac Transport System, which has been extensively adopted for coronary heart transplantation over the previous two years. Moreover, Paragonix has FDA cleared and CE marked methods for kidney, liver, and pancreas transplantation.
“Our workforce at Paragonix strives to supply donor organs and transplant recipients each attainable benefit for a second probability at life,” stated Lisa Anderson, Ph.D., Founder, President, and COO of Paragonix Applied sciences. “We’re honored to associate with the workforce at Duke and Carolina Donor Providers to achieve this unimaginable milestone and start making an influence to as many lung transplant sufferers as attainable.”
About Paragonix Applied sciences
Paragonix Technologies designs, produces, and markets organ preservation and transport units that safeguard organs through the journey between donor and transplant recipient sufferers. Our award-winning units mitigate threat in an in any other case excessive stakes setting by combining best-in class transplant merchandise with a centralized communication and knowledge switch app to eable higher coordination and effectivity throughout donor organ procurements. Paragonix SherpaPak™ CTS is the one commercially obtainable FDA-cleared and CE-marked preservation and transport machine for grownup and pediatric donor hearts destined for transplantation. Paragonix is the only sponsor of GUARDIAN, the biggest worldwide scientific knowledge registry on coronary heart preservation, capturing scientific end result knowledge on Paragonix SherpaPak™ CTS and all different coronary heart preservation applied sciences. Paragonix’s LUNGguard™ is the one FDA-cleared and CE-marked chilly storage preservation and transport machine for donor lungs and was commercially launched within the US and in Europe in December 2020. Paragonix can also be creating preservation units for pancreas, kidney and liver — designed to enhance donor organ high quality and lengthen donor organ preservation time.
Comply with us on Twitter: @ParagonixSherpa
Join with us on LinkedIn: Paragonix Technologies
Like Us on Fb: Paragonix SherpaPak
View supply model on businesswire.com:https://www.businesswire.com/news/home/20210222005619/en/
CONTACT: Michael Tajima
(781) 428.4153
mtajima@paragonixtechnologies.com
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: OTHER HEALTH GENERAL HEALTH TECHNOLOGY MEDICAL DEVICES HOSPITALS OTHER TRANSPORT CARDIOLOGY BIOTECHNOLOGY MEDICAL SUPPLIES TRANSPORT PRACTICE MANAGEMENT OTHER TECHNOLOGY HEALTH
SOURCE: Paragonix Applied sciences
Copyright Enterprise Wire 2021.
PUB: 02/22/2021 11:00 AM/DISC: 02/22/2021 11:01 AM
Copyright Enterprise Wire 2021.
— to www.oaoa.com
